NCT02794740View on ClinicalTrials.gov

Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 29, 2017

Conditions

Osteoarthritis

Interventions

DRUG

X0002

External Spray

DRUG

Placebo

External Spray

Trial Locations (1)

300000

Tianjin Xinchen-Techfields Pharma Co. Ltd, Tianjin

All Listed Sponsors

lead

Tianjin XinChen-Techfields Pharma Co., LTD.

INDUSTRY

NCT02794740 - Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers | Biotech Hunter | Biotech Hunter